Nucleus Network is a global leader in early-phase clinical trials, focusing on Phase 1 studies. The company operates dedicated clinical facilities in Australia, the United States, and the United Kingdom, ensuring speed, safety, and quality in drug development.
| Founded | 2004 (22 years) |
| Latest funding | Merger / Acquisition |
| Employees | 1,100 |
| Headquarters | Melbourne, Australia |
| Trusted networks on Proven | 2 investor, bank and government networks offer Nucleus Network Pty Ltd to their members |
Company facts from Apollo.io company data. Network, offer and redemption data from the Proven platform. A Proven Score is published once publicly named clients are verified with sources.
Source: Proven platform data, public records and vendor websites. Vendors cannot pay to change a score. Methodology. Updated 2026-10-21.